For the Inventor, By the Inventor

Enter assignee name

Research Triangle Park, NC, United States of America

Lifeedit Therapeutics, Inc.

USPTO Granted Patents = 14

EPO Patents = 3

Trademarks = 2

Forward Citations = 2

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Tedd D Elich (14 out of 23 patents)

Alexandra Briner Crawley (14 out of 16 patents)

Tyson D Bowen (12 out of 12 patents)

4. Michael Coyle (8 out of 8 patents)

5. Rodolphe Barrangou (3 out of 33 patents)

6. Joel S Parker (2 out of 5 patents)

7. Gunjan H Arya (2 out of 2 patents)

8. Mark R Moore (1 out of 38 patents)

9. Michael W Lassner (1 out of 68 patents)

14 patents: Sort by Forward Citations

1. 12435325 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2025-10-07),

2. 12398385 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2025-08-26),

3. 12398384 - DNA modifying enzymes and active fragments and variants thereof and methods of use (2025-08-26),

4. 12338455 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2025-06-24),

5. 12252718 - DNA modifying enzymes and active fragments and variants thereof and methods of use (2025-03-18),

6. 12252706 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2025-03-18),

7. 12188062 - DNA modifying enzymes and active fragments and variants thereof and methods of use (2025-01-07),

8. 12188061 - Nucleic acid molecules encoding DNA modifying enzymes and active fragments and variants thereof and compositions comprising the same (2025-01-07),

9. 12188018 - Polypeptides useful for gene editing and methods of use (2025-01-07),

10. 11981940 - DNA modifying enzymes and active fragments and variants thereof and methods of use (2024-05-14),

11. 11981916 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2024-05-14),

12. 11926843 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2024-03-12),

13. 11859181 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2024-01-02),

14. 11162114 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2021-11-02),

Lifeedit Therapeutics, Inc. is a biotechnology company focused on developing innovative gene editing therapies for genetic disorders. Our mission is to improve the lives of patients by providing cutting-edge treatments that address the root causes of their conditions. With a team of experienced scientists and researchers, we are dedicated to advancing the field of gene editing and bringing new hope to those suffering from rare and debilitating diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

14 Patents

#24 in Research Triangle Park, NC

#480 in North Carolina

#21,607 in US

#40,905 in the World

Research Triangle Park, NC, United States of America

Lifeedit Therapeutics, Inc.

Forward Citations = 2

9 inventors:

Tedd D Elich (14 out of 23 patents)

Alexandra Briner Crawley (14 out of 16 patents)

Tyson D Bowen (12 out of 12 patents)

4. Michael Coyle (8 out of 8 patents)

5. Rodolphe Barrangou (3 out of 33 patents)

Please report any incorrect information to support@idiyas.com

Loading…